Lightnews — Scholar-powered news

Adam Raymakers @araymakers.bsky.social · 1d

Happy to see that @cnn.com picked up our @jama.com on greenhouse gas emissions and inhaler usage in the US.

Original article: jamanetwork.com/journals/jam...

www.cnn.com/2025/10/06/h...

Climate pollution from inhalers has the impact of half a million cars per year, study finds | CNN

The people who are most vulnerable to the hard-to-breathe air that comes with climate change may inadvertently be adding to the problem, new research finds.

www.cnn.com

3

Adam Raymakers @araymakers.bsky.social · 1d

Really excited to share, and happy have been a part of, this new paper led by @wbfeldman.bsky.social out today in @jama.com!

We conducted a comprehensive analysis of greenhouse gas emissions associated with inhaler usage in the US.

Read it here: jamanetwork.com/journals/jam...

1 2 5

Adam Raymakers @araymakers.bsky.social · 5d

New edition of the PORTAL Post (the @portalresearch.org monthly newsletter), featuring lots of great research, including our recent publication about modelling the budget impact of gene therapies to treat sickle cell disease in the US.

Check it out here: www.linkedin.com/pulse/octobe...

October 2025 | The future of the FDA, pediatric clinical trials, and the budget impact of sickle cell therapies.

On September 30, PORTAL hosted a symposium on the future of drug regulation at the FDA, featuring conversations with Peter Marks, former Director of the Center for Biologics Evaluation and Research (C...

www.linkedin.com

1

Adam Raymakers @araymakers.bsky.social · 15d

CC: @portalresearch.org @hsph.harvard.edu @yaleschoolofmed.bsky.social @yalecancer.bsky.social

Adam Raymakers @araymakers.bsky.social · 15d

Excited to share new research led by Jessica Harvey exploring the budget impact of gene therapies for sickle cell disease, with a focus on Medicaid programs.

Co-As: @ankurfactorial.bsky.social, @leah-rand.bsky.social, @akesselheim.bsky.social, & George Goshua.

🔗: link.springer.com/article/10.1...

Modeling the Budgetary Impacts of Sickle Cell Disease Gene Therapies on State Medicaid Programs - Journal of General Internal Medicine

Journal of General Internal Medicine -

link.springer.com

2 2 6

Adam Raymakers @araymakers.bsky.social · Aug 19

The Common Sense Oncology Fellowship program is now accepting applications. Definitely a great opportunity for anyone interested in health services research and oncology!

commonsenseoncology.org/wp-content/u...

commonsenseoncology.org

Adam Raymakers @araymakers.bsky.social · Jul 28

Annual trip home to the cottage!

#CapeBretonIsland

9

Adam Raymakers @araymakers.bsky.social · Jul 18

'The FDA will ask Sarepta to stop shipping its Duchenne muscular dystrophy treatment Elevidys, an HHS official said, in what could be a final blow to the company’s hopes for the product following two patients’ deaths.'

via @endpts.com

endpoints.news/fda-asks-sar...

Breaking: FDA will ask Sarepta to stop selling Duchenne treatment, following patient deaths

FDA to request Sarepta halt shipments of DMD drug Elevidys after two patient deaths, HHS official says. Trading of $SRPT shares paused after decline.

endpoints.news

1

Adam Raymakers @araymakers.bsky.social · Jul 17

'Drugmakers [said] they were stockpiling drugs in the US as a strategy to curb the impact of potential pharma tariffs. In March, Ireland saw a massive 243% increase in pharma exports, compared to the same month last year.'

via @annajbrown.bsky.social / @endpts.com

endpoints.news/pharmaceutic...

Pharma exports from Ireland climb again as Trump's drug tariffs inch closer

New data from Ireland’s Central Statistics Office suggest that pharmaceutical companies are exporting more inventory to the US as the threat of drug tariffs persists.

endpoints.news

1

Reposted by Adam Raymakers

Madhu Pai, MD, PhD @madhupai.bsky.social · Jul 16

Fantastic postdoc fellowship opportunity @mcgill.ca!

mcgill.wd3.myworkdayjobs.com/McGill_Caree...

23 27

Adam Raymakers @araymakers.bsky.social · Jul 9

Always a super interesting read!

Notably, amongst the top 20 CEOs, average compensation was greater than $30 million.

Total compensation for the top 20 CEOs was more than $600,000,000.

Also notable that there is only one woman amongst the top 20.

via @andrewedunn.bsky.social / @endpts.com

Adam Raymakers @araymakers.bsky.social · Jul 2

Just out! The new guidelines from the Canadian Patented Medicine Prices Review Board (PMPRB) have finally been released. Changes to take effect as of January 2026.

#hta #drugprices

www.canada.ca/en/patented-...

PMPRB releases new Guidelines to monitor and review drug prices - Canada.ca

PMPRB releases new Guidelines to monitor and review drug prices

www.canada.ca

1 1

Adam Raymakers @araymakers.bsky.social · Jul 2

New Health Affairs Forefront by @akesselheim.bsky.social and @jerryavorn.bsky.social from @portalresearch.org about the impact of tariffs on the affordability and availability of medications.

www.healthaffairs.org/content/fore...

Trump’s Ongoing Tariff Chaos Will Make Medications Less Affordable And Harder To Find | Health Affairs Forefront

In his first term, Trump made a lot of noise about lowering drug prices but accomplished little of consequence. The noise continues, but it is now accompanied by new ill-conceived initiatives, includi...

www.healthaffairs.org

1

Adam Raymakers @araymakers.bsky.social · Jun 26

A little work to make one of the local #Squamish trails a bit more friendly to those riding adaptive mountain bikes.

1 5

Reposted by Adam Raymakers

Aaron Kesselheim @akesselheim.bsky.social · Jun 26

New in @jama.com, Joseph Daval and I discuss legal issues surrounding ACIP including its role in setting government policy and dealing with politically-motivated agendas arising from its new membership: jamanetwork.com/journals/jam...

Legal Challenges for the Advisory Committee on Immunization Practices

This Perspective offers an analysis of the legal foundations in the context of these and other challenges to the role of the Advisory Committee on Immunization Practices.

jamanetwork.com

3 5

Adam Raymakers @araymakers.bsky.social · Jun 25

The clinical aspect & decision aside, it's problematic for health systems that BioMarin priced Brineura at $1 million. If companies didn't charge these prices, decisions would be easier & less restrictive.

Note: Brineura's net sales in 2024 were $170 million (US alone).

www.cbc.ca/news/canada/...

Vancouver Island family heartbroken as B.C. stops funding $1M drug for girl with terminal condition | CBC News

Charleigh Pollock's mother says the family has gone through a roller-coaster of emotions since learning the B.C. government has pulled funding for the drug their daughter needs for the rare and termin...

www.cbc.ca

3

Adam Raymakers @araymakers.bsky.social · Jun 24

'A 2023 analysis of more than 20 million deaths across the world found that hot days and days with bad air quality both resulted in higher-than-normal mortality rates. But periods in which heat and pollution are combined were even more deadly.'

via @nytimes.com

Harvard Chan C-CHANGE @harvardcchange.bsky.social · Jun 24

Extreme heat & air pollution are a "double whammy" threat to public health, increasing hospital visits for respiratory, heart & mental health, says our director @maryrice-lungdr.bsky.social to @NYTimes.com. Rollbacks to air quality regulations threaten to make pollution worse https://loom.ly/BURs3N0

Extreme Heat Is Exacerbating Air Pollution, a ‘Double Whammy’ for Health

Extreme heat is making air pollution worse, scientists say. And President Trump’s regulatory rollbacks could drive air pollution even higher.

www.nytimes.com

Adam Raymakers @araymakers.bsky.social · Jun 23

Looking for a recent paper that reports on HRQoL via EQ-5D-5L/3L scores, that specifically reports on the each of the domains/levels of the EQ-5D.

Preferably in a chronic disease, and also preferably US-based (but not necessary). Anyone? @euroqol.bsky.social

#healtheconomics #hspr #QALYs

1

Adam Raymakers @araymakers.bsky.social · Jun 18

Done!

1

Reposted by Adam Raymakers

Holly Fernandez Lynch @hollylynchez.bsky.social · Jun 17

Our special issue, “Advancing Trust in Science: Institutional Obligations to Promote Research Integrity,” is now live in @jlme-journal.bsky.social. Check out the full line up of leading voices on spotting, addressing, and preventing misconduct.

www.cambridge.org/core/journal...

12 20

Adam Raymakers @araymakers.bsky.social · Jun 17

I've attended this event in the past and it's absolutely fantastic! Not to mention Galway is an incredibly fun city to visit. Highly recommend!

John Cawley @johncawley.bsky.social · Jun 17

The 5th Ireland Masterclass in Health Economics will take place at @uniofgalway.bsky.social in Galway, Ireland, March 18-20, 2026. For info and to register, visit: blogs.cornell.edu/ireland-mast...

Cc: #Econsky @ashecon.bsky.social @healtheconall.bsky.social

1 4

Adam Raymakers @araymakers.bsky.social · Jun 17

Added a few more folks recently so thought I'd re-share.

If I've missed you, reach out and I'll add you to the list!

#healtheconomics

Adam Raymakers @araymakers.bsky.social · Nov 18

I've created a #healtheconomics starter pack! There's a few other great packs out there but in this one I've tried to make it more international! 🌎

Let me know if you'd like to be added or if you have recommendations.

And feel free to share!

go.bsky.app/8Lj8FLB

2 5

Adam Raymakers @araymakers.bsky.social · Jun 16

Super interesting story about Novo Nordisk and their Canadian patents.

'... Novo did file a patent there for semaglutide. . .but the last time they paid the annual maintenance fee on it was 2018!'

by @dereklowe.bsky.social

www.science.org/content/blog...

Novo Nordisk's Canadian Mistake

www.science.org

1

Adam Raymakers @araymakers.bsky.social · Jun 9

Great and engaging panel discussion about the future of the Inflation Reduction Act by @benro.me and Chris Cai (both from @portalresearch.org), @dusetzinas.bsky.social (Vanderbilt Health Policy), and Alyson Bancroft (@p4ad.bsky.social)!

#ARM25

2 4

Adam Raymakers @araymakers.bsky.social · Jun 9

Presenting some work on spending associated with drugs for ultra-rare diseases at the @academyhealth.bsky.social
Annual Research Meeting!

#arm25 @portalresearch.org

1 2